|
Volumn 1150, Issue , 2008, Pages 217-219
|
Anti-CD20 treatment prolongs syngeneic islet graft survival and delays the onset of recurrent autoimmune diabetes
c
Mail Box 208020
*
(United States)
|
Author keywords
Anti CD20 therapy; Islet transplantation; NOD mice
|
Indexed keywords
CD20 ANTIBODY;
INSULIN;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
AUTOIMMUNE DISEASE;
CONFERENCE PAPER;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
GRAFT SURVIVAL;
HUMAN;
HYPOGLYCEMIA;
IMMUNOLOGICAL TOLERANCE;
IMMUNOSUPPRESSIVE TREATMENT;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN TREATMENT;
ISOGRAFT;
MALE;
MOUSE;
NONHUMAN;
PANCREAS ISLET TRANSPLANTATION;
RECURRENT DISEASE;
T LYMPHOCYTE ACTIVATION;
MUS;
|
EID: 57749209115
PISSN: 00778923
EISSN: 17496632
Source Type: Book Series
DOI: 10.1196/annals.1447.032 Document Type: Conference Paper |
Times cited : (7)
|
References (7)
|